Daclizumab Injection

VIAL

1 single-dose vial of 25mg lyophilized powder for injection.

Other, Injectable

sterile, lyophilized powder

Liquid

As directed by physician

Dosage Guidelines Administration: Subcutaneous injection (not IV or IM). Starting dose (adults): -thalassemia: 1 mg/kg once every 3 weeks. Myelodysplastic syndromes (MDS): 1 mg/kg once every 3 weeks. Adjustment: If response is inadequate, dose may be increased to 1.25 mg/kg (maximum). Dose interruptions or reductions may be required for side effects (e.g., high hemoglobin, hypertension, bone pain). Treatment goal: Reduce or eliminate the need for red blood cell transfusions. Reconstitution: Each vial must be reconstituted with sterile water before injection

Store below 25C

Store in Cool

Room Temperature

5000 Per Month

100 Per Day

50 Per Week

Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa

Middle East, Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Africa

Contact us for information regarding our sample policy

Contact us for information regarding our sample policy